US imposes 100% tariff on patented pharmaceutical imports
→Tariff linked to pricing deals and domestic production
- → Drugmakers must adjust pricing or production — cost pressure increases
- → Import costs rise sharply — supply chain decisions shift
Full decision brief
See the decision layer
Use 1 free preview to unlock implications, who’s affected, what to watch, and Clarify for this brief.
2 free previews left this month · Resets 1 Jun